相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Use of a Novel EEG-Based Objective Test, the Cognalyzer®, in Quantifying the Strength and Determining the Action Time of Cannabis Psychoactive Effects and Factors that May Influence Them Within an Observational Study Framework
Dan Bosnyak et al.
NEUROLOGY AND THERAPY (2022)
Exploring the impact of adolescent exposure to cannabinoids and nicotine on psychiatric risk: insights from translational animal models
Steven R. Laviolette
PSYCHOLOGICAL MEDICINE (2021)
Comparison of Five Oral Cannabidiol Preparations in Adult Humans: Pharmacokinetics, Body Composition, and Heart Rate Variability
Natasha N. Bondareva Williams et al.
PHARMACEUTICALS (2021)
Pharmacokinetic Investigation of Commercially Available Edible Marijuana Products in Humans: Potential Influence of Body Composition and Influence on Glucose Control
Taylor Russell Ewell et al.
PHARMACEUTICALS (2021)
Enhancing Efficacy, Performance, and Reliability of Cannabis Edibles: Insights from Lipid Bioavailability Studies
David Julian McClements
ANNUAL REVIEW OF FOOD SCIENCE AND TECHNOLOGY, VOL 11 (2020)
Towards Better Delivery of Cannabidiol (CBD)
Sophie Anne Millar et al.
PHARMACEUTICALS (2020)
Changing the tone of clinical study design in the cannabis industry
Joseph M. Antony et al.
TRANSLATIONAL NEUROSCIENCE (2020)
Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation
Roger Hudson et al.
JOURNAL OF NEUROSCIENCE (2019)
A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb® Formulation Technology Improving the Oral Bioavailability of Cannabidiol in Healthy Subjects
Katharina Knaub et al.
MOLECULES (2019)
Human Pharmacokinetic Parameters of Orally Administered Δ9-Tetrahydrocannabinol Capsules Are Altered by Fed Versus Fasted Conditions and Sex Differences
Stephanie Lunn et al.
CANNABIS AND CANNABINOID RESEARCH (2019)
The pharmacokinetics and the pharmacodynamics of cannabinoids
Catherine J. Lucas et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
PTL401, a New Formulation Based on Pro-Nano Dispersion Technology, Improves Oral Cannabinoids Bioavailability in Healthy Volunteers
Jacob Atsmon et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function
Celia J. A. Morgan et al.
TRANSLATIONAL PSYCHIATRY (2018)
Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
Jose A. Crippa et al.
FRONTIERS IN IMMUNOLOGY (2018)
A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
Sophie A. Millar et al.
FRONTIERS IN PHARMACOLOGY (2018)
Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes
Ryan Vandrey et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2017)
Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration
Irina Cherniakov et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Sex differences in the subjective effects of oral Δ9-THC in cannabis users
Jessica S. Fogel et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2017)
Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake
Matthew N. Newmeyer et al.
CLINICAL CHEMISTRY (2016)
Utilization of nanoemulsions to enhance bioactivity of pharmaceuticals, supplements, and nutraceuticals: Nanoemulsion delivery systems and nanoemulsion excipient systems
Khaled Omer Aboalnaja et al.
EXPERT OPINION ON DRUG DELIVERY (2016)
Excipient Nanoemulsions for Improving Oral Bioavailability of Bioactives
Laura Salvia-Trujillo et al.
NANOMATERIALS (2016)
Circadian Rhythm of Circulating Levels of the Endocannabinoid 2-Arachidonoylglycerol
E. C. Hanlon et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Cannabidiol as a Potential Treatment for Anxiety Disorders
Esther M. Blessing et al.
NEUROTHERAPEUTICS (2015)
Early Cannabis Use, Polygenic Risk Score for Schizophrenia, and Brain Maturation in Adolescence
Leon French et al.
JAMA PSYCHIATRY (2015)
Heat Exposure of Cannabis sativa Extracts Affects the Pharmacokinetic and Metabolic Profile in Healthy Male Subjects
Martin Eichler et al.
PLANTA MEDICA (2012)
Cannabidiol in Humans-The Quest for Therapeutic Targets
Simon Zhornitsky et al.
PHARMACEUTICALS (2012)
Plasma Cannabinoid Pharmacokinetics following Controlled Oral Delta(9)-Tetrahydrocannabinol and Oromucosal Cannabis Extract Administration
Erin L. Karschner et al.
CLINICAL CHEMISTRY (2011)
Endocannabinoid Binding to the Cannabinoid Receptors: What Is Known and What Remains Unknown
Patricia H. Reggio
CURRENT MEDICINAL CHEMISTRY (2010)
Pharmacokinetic Properties of Delta(9)-Tetrahydrocannabinol in Oral Fluid of Occasional and Chronic Users
Stefan W. Toennes et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2010)
Do Δ9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?
Erin L. Karschner et al.
ADDICTION (2009)
Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes
David J. Waxman et al.
MOLECULAR PHARMACOLOGY (2009)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Hormones of the gut-brain axis as targets for the treatment of upper gastrointestinal disorders
Gareth J. Sanger et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Human cannabinoid pharmacokinetics
Marilyn A. Huestis
CHEMISTRY & BIODIVERSITY (2007)
Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Δ9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract
T Nadulski et al.
THERAPEUTIC DRUG MONITORING (2005)
Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract
T Nadulski et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2005)
Effects of cannabidiol (CBD) on regional cerebral blood flow
JAD Crippa et al.
NEUROPSYCHOPHARMACOLOGY (2004)
分享论文
